TCMBANKIN058901 |
zeatin |
(E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; NCGC00142544-01; Zeatin; Z0876_SIGMA; Z1626_SIGMA; 2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; CHEBI:16522; TNP00322; BRN 0616241; trans-Zeatin-8-14C; N6-(4-Hydroxy-3-methyl-2-buten-1-yl)adenine; Zeatine; trans-Zeatin hydrochloride; (E)-2-methyl-4-(purin-6-ylamino)-2-buten-1-ol; C00371; SMR000471895; 96088_FLUKA; 2-buten-1-ol, 2-methyl-4-(9H-purin-6-ylamino)-, (2E)-; ST057583; 1637-39-4; Z0164_SIGMA; Z2753_SIGMA; NCGC00017372-01; (E)-2-methyl-4-(1H-purin-6-ylamino)-2-buten-1-ol; 2-BUTEN-1-OL, 2-METHYL-4-(PURIN-6-YLAMINO)-, (E)-; MLS001074742; 2-Buten-1-ol, 2-methyl-4-(1H-purin-6-ylamino)-, (E)-; CHEBI:15333; (E)-Zeatin; 6-[4-hydroxy-3-methyl-but-2-enylamino]adenine; 2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; InChI=1/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2; (2E)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; trans-Zeatin; ZINC04492895; ZINC01532631; N6-(4-Hydroxyisopentenyl)adenine; 6-(4-Hydroxy-3-methylbut-2-enylamino)purine; (E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol; 2-methyl-4-(1H-purine-6-ylamino)-2-buten-1-ol; trans-zeatin |
C10H13N5O |
219.24 g/mol |
CC(=CCNC1=NC=NC2=C1NC=N2)CO |